Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Gastric Cancer

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    October 2019
  1. JANSEN M, Banks M
    Early detection and risk stratification of gastric cancer are likely to be refined with biopsies targeted through high-resolution-enhanced imaging.
    Gut. 2019 Oct 14. pii: gutjnl-2019-319921. doi: 10.1136/gutjnl-2019-319921.
    PubMed     Text format    


  2. WANG Q, Chen C, Ding Q, Zhao Y, et al
    METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance.
    Gut. 2019 Oct 3. pii: gutjnl-2019-319639. doi: 10.1136/gutjnl-2019-319639.
    PubMed     Text format     Abstract available


    September 2019
  3. LIU K, Qin M, Huang J
    The prescreening tool for gastric cancer in China.
    Gut. 2019 Sep 3. pii: gutjnl-2019-319591. doi: 10.1136/gutjnl-2019-319591.
    PubMed     Text format    


  4. CHEUNG KS, Leung WK
    Response to letter to the editor by Moayyedi et al.
    Gut. 2019;68:1721-1722.
    PubMed     Text format    


  5. BANKS M, Graham D, Jansen M, Gotoda T, et al
    British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.
    Gut. 2019;68:1545-1575.
    PubMed     Text format     Abstract available


    August 2019
  6. YAN C, Zhu M, Ding Y, Yang M, et al
    Meta-analysis of genome-wide association studies and functional assays decipher susceptibility genes for gastric cancer in Chinese populations.
    Gut. 2019 Aug 5. pii: gutjnl-2019-318760. doi: 10.1136/gutjnl-2019-318760.
    PubMed     Text format     Abstract available


    July 2019
  7. LIAO P, Jia F, Teer JK, Knepper TC, et al
    Geographic variation in molecular subtype for gastric adenocarcinoma.
    Gut. 2019;68:1340-1341.
    PubMed     Text format    


    June 2019
  8. RUGGE M, Sacchi D, Graham DY, Genta RM, et al
    Secondary prevention of gastric cancer: merging the endoscopic atrophic border with OLGA staging.
    Gut. 2019 Jun 11. pii: gutjnl-2019-319107. doi: 10.1136/gutjnl-2019-319107.
    PubMed     Text format    


    May 2019
  9. XU C, Ooi WF, Qamra A, Tan J, et al
    HNF4alpha pathway mapping identifies wild-type IDH1 as a targetable metabolic node in gastric cancer.
    Gut. 2019 May 8. pii: gutjnl-2018-318025. doi: 10.1136/gutjnl-2018-318025.
    PubMed     Text format     Abstract available


    April 2019
  10. QUACH DT, Hiyama T, Gotoda T
    Do subjects with mild or moderate atrophic gastritis or intestinal metaplasia confined to the antrum benefit from gastric cancer surveillance?
    Gut. 2019 Apr 27. pii: gutjnl-2019-318720. doi: 10.1136/gutjnl-2019-318720.
    PubMed     Text format    


  11. DEN HOLLANDER WJ, Holster IL, den Hoed CM, Capelle LG, et al
    Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions.
    Gut. 2019;68:585-593.
    PubMed     Text format     Abstract available


    March 2019
  12. CAI Q, Zhu C, Yuan Y, Feng Q, et al
    Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study.
    Gut. 2019 Mar 29. pii: gutjnl-2018-317556. doi: 10.1136/gutjnl-2018-317556.
    PubMed     Text format     Abstract available


  13. WANG P, Wang Y, Langley SA, Zhou YX, et al
    Diverse tumour susceptibility in Collaborative Cross mice: identification of a new mouse model for human gastric tumourigenesis.
    Gut. 2019 Mar 6. pii: gutjnl-2018-316691. doi: 10.1136/gutjnl-2018-316691.
    PubMed     Text format     Abstract available


    January 2019
  14. LIN C, He H, Liu H, Li R, et al
    Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer.
    Gut. 2019 Jan 19. pii: gutjnl-2018-316324. doi: 10.1136/gutjnl-2018-316324.
    PubMed     Text format     Abstract available


  15. LI T, Guo H, Li H, Jiang Y, et al
    MicroRNA-92a-1-5p increases CDX2 by targeting FOXD1 in bile acids-induced gastric intestinal metaplasia.
    Gut. 2019 Jan 11. pii: gutjnl-2017-315318. doi: 10.1136/gutjnl-2017-315318.
    PubMed     Text format     Abstract available


  16. RAHN S, Kruger S, Rocken C, Helm O, et al
    Response to: 'Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma'.
    Gut. 2019;68:179-180.
    PubMed     Text format    


    September 2018
  17. WANG DS, Liu ZX, Lu YX, Bao H, et al
    Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer.
    Gut. 2018 Sep 29. pii: gutjnl-2018-316522. doi: 10.1136/gutjnl-2018-316522.
    PubMed     Text format     Abstract available


    July 2018
  18. CHUANG SC, Lin CC, Peng CY, Huang WH, et al
    Proton pump inhibitors increase the risk of cholecystitis: a population-based case-control study.
    Gut. 2018 Jul 17. pii: gutjnl-2018-316899. doi: 10.1136/gutjnl-2018-316899.
    PubMed     Text format    


  19. MOAYYEDI P, Veldhuyzen van Zanten SJO, Hookey L, Armstrong D, et al
    Proton pump inhibitors and gastric cancer: association is not causation.
    Gut. 2018 Jul 13. pii: gutjnl-2018-316958. doi: 10.1136/gutjnl-2018-316958.
    PubMed     Text format    


    May 2018
  20. KOBAYASHI J, Uchida H, Ito J
    Long-term proton pump inhibitor use after Helicobacter pylori eradication may create a gastric environment for N-nitrosamine formation and gastric cancer development.
    Gut. 2018 May 25. pii: gutjnl-2018-316592. doi: 10.1136/gutjnl-2018-316592.
    PubMed     Text format    


    April 2018
  21. SEIDLITZ T, Merker SR, Rothe A, Zakrzewski F, et al
    Human gastric cancer modelling using organoids.
    Gut. 2018 Apr 27. pii: gutjnl-2017-314549. doi: 10.1136/gutjnl-2017-314549.
    PubMed     Text format     Abstract available


  22. LAI SW, Lai HC, Lin CL, Liao KF, et al
    Proton pump inhibitors and risk of gastric cancer in a case-control study.
    Gut. 2018 Apr 16. pii: gutjnl-2018-316371. doi: 10.1136/gutjnl-2018-316371.
    PubMed     Text format    


  23. WAN QY, Wu XT, Li N, Du L, et al
    Long-term proton pump inhibitors use and risk of gastric cancer: a meta-analysis of 926 386 participants.
    Gut. 2018 Apr 3. pii: gutjnl-2018-316416. doi: 10.1136/gutjnl-2018-316416.
    PubMed     Text format    


    March 2018
  24. COOK MB, Coburn SB, Lam JR, Taylor PR, et al
    Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort.
    Gut. 2018;67:418-529.
    PubMed     Text format     Abstract available


    February 2018
  25. PENG YC, Huang LR, Lin CL, Hsu WY, et al
    Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD.
    Gut. 2018 Feb 22. pii: gutjnl-2018-316057. doi: 10.1136/gutjnl-2018-316057.
    PubMed     Text format    


  26. FERREIRA RM, Pereira-Marques J, Pinto-Ribeiro I, Costa JL, et al
    Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota.
    Gut. 2018;67:226-236.
    PubMed     Text format     Abstract available


    January 2018
  27. DOORAKKERS E, Lagergren J, Engstrand L, Brusselaers N, et al
    Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population.
    Gut. 2018 Jan 30. pii: gutjnl-2017-315363. doi: 10.1136/gutjnl-2017-315363.
    PubMed     Text format     Abstract available


  28. LATERZA L, Scaldaferri F, Gasbarrini A
    Risk factors for gastric cancer: is it time to discard PPIs?
    Gut. 2018 Jan 13. pii: gutjnl-2017-315621. doi: 10.1136/gutjnl-2017-315621.
    PubMed     Text format    


  29. RUGGE M, Meggio A, Pravadelli C, Barbareschi M, et al
    Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients.
    Gut. 2018 Jan 6. pii: gutjnl-2017-314600. doi: 10.1136/gutjnl-2017-314600.
    PubMed     Text format     Abstract available


  30. SUISSA S, Suissa A
    Proton-pump inhibitors and increased gastric cancer risk: time-related biases.
    Gut. 2018 Jan 3. pii: gutjnl-2017-315729. doi: 10.1136/gutjnl-2017-315729.
    PubMed     Text format    


    December 2017
  31. NIIKURA R, Hayakawa Y, Hirata Y, Yamada A, et al
    Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis.
    Gut. 2017 Dec 22. pii: gutjnl-2017-315710. doi: 10.1136/gutjnl-2017-315710.
    PubMed     Text format    


  32. SUZUKI H, Matsuzaki J
    Helicobacter pylori eradication failure may have confounded the recent large-scale health database study that showed proton pump inhibitors increase gastric cancer risk.
    Gut. 2017 Dec 15. pii: gutjnl-2017-315698. doi: 10.1136/gutjnl-2017-315698.
    PubMed     Text format    


    November 2017
  33. GUETA I, Halkin H, Markovits N, Loebstein R, et al
    Proton pump inhibitors and the risk for gastric cancer: possible confounding by serum vitamin B 12.
    Gut. 2017 Nov 28. pii: gutjnl-2017-315695. doi: 10.1136/gutjnl-2017-315695.
    PubMed     Text format    


  34. WALDUM HL, Fossmark R
    Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in man.
    Gut. 2017 Nov 20. pii: gutjnl-2017-315629. doi: 10.1136/gutjnl-2017-315629.
    PubMed     Text format    



  35. Erratum: Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids.
    Gut. 2017;66:2012.
    PubMed     Text format    


    October 2017
  36. CHEUNG KS, Chan EW, Wong AYS, Chen L, et al
    Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study.
    Gut. 2017 Oct 31. pii: gutjnl-2017-314605. doi: 10.1136/gutjnl-2017-314605.
    PubMed     Text format     Abstract available


    September 2017
  37. CHEN IF, Liu KW, Tang TQ, Wang WL, et al
    An unusual gastric tumour with gastric outlet obstruction.
    Gut. 2017 Sep 28. pii: gutjnl-2017-315087. doi: 10.1136/gutjnl-2017-315087.
    PubMed     Text format    


  38. YAN C, Zhu M, Huang T, Yu F, et al
    Genome-wide association studies identified loci contribute to phenotypic variance of gastric cancer.
    Gut. 2017 Sep 22. pii: gutjnl-2017-315230. doi: 10.1136/gutjnl-2017-315230.
    PubMed     Text format    


  39. NOTO JM, Chopra A, Loh JT, Romero-Gallo J, et al
    Pan-genomic analyses identify key Helicobacter pylori pathogenic loci modified by carcinogenic host microenvironments.
    Gut. 2017 Sep 18. pii: gutjnl-2017-313863. doi: 10.1136/gutjnl-2017-313863.
    PubMed     Text format     Abstract available


    August 2017
  40. RAJENDRAN S, Benna C, Monticelli H, Spiro G, et al
    Germline variation of circadian pathway genes and prognosis of gastric cancer patients.
    Gut. 2017 Aug 8. pii: gutjnl-2017-314740. doi: 10.1136/gutjnl-2017-314740.
    PubMed     Text format    


  41. COKER OO, Dai Z, Nie Y, Zhao G, et al
    Mucosal microbiome dysbiosis in gastric carcinogenesis.
    Gut. 2017 Aug 1. pii: gutjnl-2017-314281. doi: 10.1136/gutjnl-2017-314281.
    PubMed     Text format     Abstract available


    June 2017
  42. HUANG LY, Wang X, Cui XF, Li H, et al
    IRTKS is correlated with progression and survival time of patients with gastric cancer.
    Gut. 2017 Jun 24. pii: gutjnl-2016-313478. doi: 10.1136/gutjnl-2016-313478.
    PubMed     Text format     Abstract available


  43. MERA RM, Bravo LE, Camargo MC, Bravo JC, et al
    Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial.
    Gut. 2017 Jun 24. pii: gutjnl-2016-311685. doi: 10.1136/gutjnl-2016-311685.
    PubMed     Text format     Abstract available


    May 2017
  44. SIERRA JC, Asim M, Verriere TG, Piazuelo MB, et al
    Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis.
    Gut. 2017 May 4. pii: gutjnl-2016-312888. doi: 10.1136/gutjnl-2016-312888.
    PubMed     Text format     Abstract available


  45. THOMPSON ED, Zahurak M, Murphy A, Cornish T, et al
    Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma.
    Gut. 2017;66:794-801.
    PubMed     Text format     Abstract available


    April 2017
  46. WANG Z, Dai J, Hu N, Miao X, et al
    Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies.
    Gut. 2017;66:581-587.
    PubMed     Text format     Abstract available


    March 2017
  47. ZHANG X, Xu W
    Neutrophils diminish T-cell immunity to foster gastric cancer progression: the role of GM-CSF/PD-L1/PD-1 signalling pathway.
    Gut. 2017 Mar 27. pii: gutjnl-2017-313923. doi: 10.1136/gutjnl-2017-313923.
    PubMed     Text format    


  48. WANG TT, Zhao YL, Peng LS, Chen N, et al
    Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway.
    Gut. 2017 Mar 8. pii: gutjnl-2016-313075. doi: 10.1136/gutjnl-2016-313075.
    PubMed     Text format     Abstract available


    December 2016
  49. MAEDA M, Nakajima T, Oda I, Shimazu T, et al
    High impact of methylation accumulation on metachronous gastric cancer: 5-year follow-up of a multicentre prospective cohort study.
    Gut. 2016 Dec 21. pii: gutjnl-2016-313387. doi: 10.1136/gutjnl-2016-313387.
    PubMed     Text format    


    October 2016
  50. MALFERTHEINER P, Megraud F, O'Morain CA, Gisbert JP, et al
    Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
    Gut. 2016 Oct 5. pii: gutjnl-2016-312288. doi: 10.1136/gutjnl-2016-312288.
    PubMed     Text format     Abstract available


    September 2016
  51. ZHU S, Soutto M, Chen Z, Peng D, et al
    Helicobacter pylori-induced cell death is counteracted by NF-kappaB-mediated transcription of DARPP-32.
    Gut. 2016 Sep 2. pii: gutjnl-2016-312141. doi: 10.1136/gutjnl-2016-312141.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: